Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review.

导出 LinkOut

翻译打印收藏纠错

作者： Harmen R,Moes ^[1] ; Tove,Henriksen ^[2] ; Jarosław,Sławek ^[3] ; Onanong,Phokaewvarangkul ^[4] ; Erik,Buskens ^[5] ; Teus,van Laar ^[6]

作者单位： Department of Neurology, University of Groningen, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands. ^[1] Department of Neurology, Movement Disorder Clinic, Bispebjerg Hospital, Copenhagen, Denmark. ^[2] Department of Neurology, St Adalbert Hospital Copernicus, Gdansk, Poland. ^[3] Department of Neurological and Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland. ^[4] Chulalongkorn Center of Excellence for Parkinson Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. ^[5] Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. ^[6] Department of Neurology, University of Groningen, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands. t.van.laar@umcg.nl. ^[7]

关键词 CSAI DBS Device-aided therapies LCIG Parkinson’s disease Screening tools

主题词人类(Humans);帕金森病(Parkinson Disease);抗震颤麻痹药(Antiparkinson Agents);卡比多巴(Carbidopa);左旋多巴(Levodopa);复方合剂(Drug Combinations);凝胶类(Gels)

DOI 10.1007/s00702-023-02656-z

PMID 37500937

发布时间 2024-01-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交